260660 Stock Chart & Stats
₩2305.00
-₩45.00(-1.91%)
―
--
Day’s Range― - ―
52-Week Range₩2,205.00 - ₩5,760.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)162.38K
Market Cap
₩35.28B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.08
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding15,327,021
10 Day Avg. Volume143,580
30 Day Avg. Volume162,375
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
260660 FAQ
What was KOREA ARLICO PHARM CO.,LTD.’s price range in the past 12 months?
KOREA ARLICO PHARM CO.,LTD. lowest stock price was ₩2205.00 and its highest was ₩5760.00 in the past 12 months.
What is KOREA ARLICO PHARM CO.,LTD.’s market cap?
KOREA ARLICO PHARM CO.,LTD.’s market cap is ₩35.28B.
When is KOREA ARLICO PHARM CO.,LTD.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were KOREA ARLICO PHARM CO.,LTD.’s earnings last quarter?
KOREA ARLICO PHARM CO.,LTD. released its earnings results on May 20, 2026. The company reported -₩41.336 earnings per share for the quarter, missing the consensus estimate of N/A by -₩41.336.
Is KOREA ARLICO PHARM CO.,LTD. overvalued?
According to Wall Street analysts KOREA ARLICO PHARM CO.,LTD.’s price is currently Undervalued.
Does KOREA ARLICO PHARM CO.,LTD. pay dividends?
KOREA ARLICO PHARM CO.,LTD. does not currently pay dividends.
What is KOREA ARLICO PHARM CO.,LTD.’s EPS estimate?
KOREA ARLICO PHARM CO.,LTD.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does KOREA ARLICO PHARM CO.,LTD. have?
KOREA ARLICO PHARM CO.,LTD. has 15,327,021 shares outstanding.
What happened to KOREA ARLICO PHARM CO.,LTD.’s price movement after its last earnings report?
KOREA ARLICO PHARM CO.,LTD. reported an EPS of -₩41.336 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.665%.
Which hedge fund is a major shareholder of KOREA ARLICO PHARM CO.,LTD.?
Currently, no hedge funds are holding shares in KR:260660
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Korean Drug Co., Ltd
―
HLB Pep Co. Ltd.
―
SYNTEKABIO, INC.
―
KAINOS MEDICINE INC.
―
Oncocross Co., Ltd.
―